oxycodone and rifampin

oxycodone has been researched along with rifampin in 9 studies

Research

Studies (9)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (66.67)29.6817
2010's3 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Strassburg, CP; Tukey, RH1
Lombardo, F; Obach, RS; Waters, NJ1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S1
Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Lee, HK; Lewis, LD; McMullin, M; Schur, BC; Tsongalis, GJ; Wong, SH; Yeo, KT1
Hagelberg, NM; Laine, K; Neuvonen, M; Neuvonen, PJ; Nieminen, TH; Olkkola, KT; Pertovaara, A; Saari, TI1
Hori, Y; Matsuda, S; Okamoto, T; Sakamoto, A; Shimizu, A; Yamashita, M1

Reviews

2 review(s) available for oxycodone and rifampin

ArticleYear
Human UDP-glucuronosyltransferases: metabolism, expression, and disease.
    Annual review of pharmacology and toxicology, 2000, Volume: 40

    Topics: Autoimmunity; Chromosome Mapping; Glucuronides; Glucuronosyltransferase; Humans; Hyperbilirubinemia; Neoplasms; Steroids; Terminology as Topic

2000
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Trials

1 trial(s) available for oxycodone and rifampin

ArticleYear
Rifampin greatly reduces the plasma concentrations of intravenous and oral oxycodone.
    Anesthesiology, 2009, Volume: 110, Issue:6

    Topics: Administration, Oral; Adult; Analgesics, Opioid; Anti-Bacterial Agents; Biological Availability; Cross-Over Studies; Cytochrome P-450 CYP3A; Double-Blind Method; Drug Interactions; Enzyme Induction; Female; Half-Life; Humans; Injections, Intravenous; Male; Oxycodone; Rifampin; Young Adult

2009

Other Studies

6 other study(ies) available for oxycodone and rifampin

ArticleYear
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
    Journal of medicinal chemistry, 2009, Oct-22, Volume: 52, Issue:20

    Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley

2009
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
    Drug metabolism and disposition: the biological fate of chemicals, 2011, Volume: 39, Issue:3

    Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution

2011
Negative urine opioid screening caused by rifampin-mediated induction of oxycodone hepatic metabolism.
    Clinica chimica acta; international journal of clinical chemistry, 2006, Volume: 367, Issue:1-2

    Topics: Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme System; Gas Chromatography-Mass Spectrometry; Genotype; Humans; Liver; Male; Middle Aged; Molecular Structure; Narcotics; Oxycodone; Rifampin

2006
Oxycodone Resistance Due to Rifampin Use in an Osteosarcoma Patient with Tuberculosis.
    The American journal of case reports, 2017, Oct-24, Volume: 18

    Topics: Adult; Analgesics, Opioid; Antibiotics, Antitubercular; Bone Neoplasms; Cancer Pain; Drug Resistance; Humans; Lung Neoplasms; Male; Osteosarcoma; Oxycodone; Rifampin; Tuberculosis, Pulmonary

2017